• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

SEOM-TTCC 鼻咽癌临床指南（2021）。

SEOM-TTCC clinical guideline in nasopharynx cancer (2021).

机构信息

Medical Oncology Intercenter Unit, Regional and Virgen de La Victoria University Hospitals, IBIMA, 29010, Málaga, Spain.

Medical Oncology Department. Catalan Institut of Oncology - Badalona. B-ARGO Group, IGTP, Badalona, Spain.

出版信息

Clin Transl Oncol. 2022 Apr;24(4):670-680. doi: 10.1007/s12094-022-02814-x. Epub 2022 Mar 18.

DOI:10.1007/s12094-022-02814-x
PMID:35303267
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8986714/
Abstract

Nasopharyngeal carcinoma (NPC) is distinct from other cancers of the head and neck in biology, epidemiology, histology, natural history, and response to treatment. Radiotherapy (RT) is the cornerstone of locoregional treatment of non-disseminated disease and the association of chemotherapy improves the rates of survival. In the case of metastatic disease stages, treatment requires platinum/gemcitabine-based chemotherapy and patients may achieve a long survival time.

摘要

鼻咽癌（NPC）在生物学、流行病学、组织学、自然史和对治疗的反应方面与头颈部的其他癌症不同。放射治疗（RT）是局部区域治疗非播散性疾病的基石，联合化疗可提高生存率。对于转移性疾病分期，治疗需要基于铂类/吉西他滨的化疗，患者可能实现长期生存。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fd6/8986714/5f28710b6db8/12094_2022_2814_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fd6/8986714/257ff6537120/12094_2022_2814_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fd6/8986714/5f28710b6db8/12094_2022_2814_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fd6/8986714/257ff6537120/12094_2022_2814_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fd6/8986714/5f28710b6db8/12094_2022_2814_Fig2_HTML.jpg

相似文献

1
SEOM-TTCC clinical guideline in nasopharynx cancer (2021).SEOM-TTCC 鼻咽癌临床指南（2021）。
Clin Transl Oncol. 2022 Apr;24(4):670-680. doi: 10.1007/s12094-022-02814-x. Epub 2022 Mar 18.
2
SEOM clinical guideline in nasopharynx cancer (2017).头颈部肿瘤临床实践指南（2017 年）
Clin Transl Oncol. 2018 Jan;20(1):84-88. doi: 10.1007/s12094-017-1777-0. Epub 2017 Nov 2.
3
SEOM clinical guidelines for the treatment of nasopharyngeal carcinoma 2013.2013 年 SEOM 鼻咽癌治疗临床指南。
Clin Transl Oncol. 2013 Dec;15(12):1025-9. doi: 10.1007/s12094-013-1094-1. Epub 2013 Aug 27.
4
Adapted strategy to tumor response in childhood nasopharyngeal carcinoma: the French experience.适应儿童鼻咽癌肿瘤反应的策略：法国经验。
Strahlenther Onkol. 2019 Jun;195(6):504-516. doi: 10.1007/s00066-019-01461-6. Epub 2019 Apr 8.
5
Sequential induction chemotherapy plus intensity-modulated radiotherapy versus concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: the three-year report of a phase II, single center, randomized, non-inferiority trial.序贯诱导化疗加调强放疗与同期放化疗治疗局部晚期鼻咽癌：一项 II 期、单中心、随机、非劣效性试验的三年报告。
Cancer Med. 2021 Jun;10(12):3886-3895. doi: 10.1002/cam4.3936. Epub 2021 May 6.
6
Chemotherapy in Combination With Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma: CSCO and ASCO Guideline.《CSCO/ASCO 鼻咽癌临床诊疗指南》：放化疗用于局部晚期鼻咽癌的根治性治疗
J Clin Oncol. 2021 Mar 1;39(7):840-859. doi: 10.1200/JCO.20.03237. Epub 2021 Jan 6.
7
Impact of different therapeutic regimens on survival of patients with nasopharyngeal carcinoma.不同治疗方案对鼻咽癌患者生存的影响。
J BUON. 2019 Nov-Dec;24(6):2418-2422.
8
Induction chemotherapy with lobaplatin and fluorouracil versus cisplatin and fluorouracil followed by chemoradiotherapy in patients with stage III-IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised, controlled, phase 3 trial.洛铂联合氟尿嘧啶与顺铂联合氟尿嘧啶诱导化疗后同期放化疗治疗局部晚期鼻咽癌的随机、开放、非劣效、对照、Ⅲ期临床试验
Lancet Oncol. 2021 May;22(5):716-726. doi: 10.1016/S1470-2045(21)00075-9. Epub 2021 Apr 12.
9
Systemic chemotherapy and sequential locoregional radiotherapy in initially metastatic nasopharyngeal carcinoma: Retrospective analysis with 821 cases.初治转移性鼻咽癌的全身化疗序贯局部区域放疗：821例回顾性分析
Head Neck. 2020 Aug;42(8):1970-1980. doi: 10.1002/hed.26130. Epub 2020 Mar 10.
10
Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis.鼻咽癌的化学治疗与放射治疗：MAC-NPC 荟萃分析更新。
Lancet Oncol. 2015 Jun;16(6):645-55. doi: 10.1016/S1470-2045(15)70126-9. Epub 2015 May 6.

引用本文的文献

1
The Functional Interaction Between Epstein-Barr Virus and MYC in the Pathogenesis of Burkitt Lymphoma.爱泼斯坦-巴尔病毒与MYC在伯基特淋巴瘤发病机制中的功能相互作用
Cancers (Basel). 2024 Dec 18;16(24):4212. doi: 10.3390/cancers16244212.
2
Head and Neck Squamous Cell Carcinoma: Insights from Dual-Energy Computed Tomography (DECT).头颈部鳞状细胞癌：双能 CT 检测的新视角。
Tomography. 2024 Nov 11;10(11):1780-1797. doi: 10.3390/tomography10110131.
3
Incidence of Carotid Blowout Syndrome in Patients with Head and Neck Cancer after Radiation Therapy: A Cohort Study.

本文引用的文献

1
Camrelizumab versus placebo in combination with gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma (CAPTAIN-1st): a multicentre, randomised, double-blind, phase 3 trial.卡瑞利珠单抗联合吉西他滨和顺铂与安慰剂联合吉西他滨和顺铂用于复发或转移性鼻咽癌的一线治疗（CAPTAIN-1st）：一项多中心、随机、双盲、III 期临床试验。
Lancet Oncol. 2021 Aug;22(8):1162-1174. doi: 10.1016/S1470-2045(21)00302-8. Epub 2021 Jun 23.
2
Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial.节拍式卡培他滨作为局部晚期鼻咽癌辅助治疗：一项多中心、开放标签、平行分组、随机、对照、3 期临床试验。
Lancet. 2021 Jul 24;398(10297):303-313. doi: 10.1016/S0140-6736(21)01123-5. Epub 2021 Jun 7.
3
头颈部癌患者放疗后颈动脉破裂综合征的发生率：一项队列研究
Diagnostics (Basel). 2024 Jun 9;14(12):1222. doi: 10.3390/diagnostics14121222.
4
Precision Medicine for Nasopharyngeal Cancer-A Review of Current Prognostic Strategies.鼻咽癌的精准医学——当前预后策略综述
Cancers (Basel). 2024 Feb 24;16(5):918. doi: 10.3390/cancers16050918.
5
An Evaluation of Treatment Outcomes and Associated Factors in Nasopharyngeal Cancer Patients at a Tertiary Cancer Center in the United Arab Emirates.阿拉伯联合酋长国一家三级癌症中心鼻咽癌患者的治疗结果及相关因素评估
Cureus. 2024 Feb 17;16(2):e54344. doi: 10.7759/cureus.54344. eCollection 2024 Feb.
6
Precision medicine in nasopharyngeal carcinoma: comprehensive review of past, present, and future prospect.鼻咽癌精准医学：过去、现在和未来展望的全面综述。
J Transl Med. 2023 Nov 6;21(1):786. doi: 10.1186/s12967-023-04673-8.
7
[Role of chemotherapy in radiotherapy-treated nasopharynx carcinoma: update of the MAC-NPC network meta-analysis].[化疗在鼻咽癌放疗中的作用：MAC-NPC网络荟萃分析的更新]
Strahlenther Onkol. 2024 Jan;200(1):99-102. doi: 10.1007/s00066-023-02164-9. Epub 2023 Oct 19.
8
Assessing the methodological strengths and limitations of the Spanish Society of Medical Oncology (SEOM) guidelines: a critical appraisal using AGREE II and AGREE-REX tool.评估西班牙肿瘤内科学会（SEOM）指南的方法学优势和局限性：使用 AGREE II 和 AGREE-REX 工具进行批判性评估。
Clin Transl Oncol. 2024 Jan;26(1):85-97. doi: 10.1007/s12094-023-03219-0. Epub 2023 Jun 27.
9
Early Stage and Locally Advanced Nasopharyngeal Carcinoma Treatment from Present to Future: Where Are We and Where Are We Going?早期和局部晚期鼻咽癌治疗：从现在到未来，我们在哪里，我们要去哪里？
Curr Treat Options Oncol. 2023 Jul;24(7):845-866. doi: 10.1007/s11864-023-01083-2. Epub 2023 May 5.
10
SEOM clinical guidelines (2021).SEOM临床指南（2021年）
Clin Transl Oncol. 2022 Apr;24(4):611-612. doi: 10.1007/s12094-022-02825-8. Epub 2022 Apr 1.
The Most Efficacious Induction Chemotherapy Regimen for Locoregionally Advanced Nasopharyngeal Carcinoma: A Network Meta-Analysis.局部晚期鼻咽癌最有效的诱导化疗方案：一项网状Meta分析
Front Oncol. 2021 Feb 25;11:626145. doi: 10.3389/fonc.2021.626145. eCollection 2021.
4
Types of Transnasal Endoscopic Nasopharyngectomy for Recurrent Nasopharyngeal Carcinoma: Shanghai EENT Hospital Experience.复发性鼻咽癌经鼻内镜鼻咽切除术的类型：上海眼耳鼻喉科医院经验
Front Oncol. 2021 Jan 14;10:555862. doi: 10.3389/fonc.2020.555862. eCollection 2020.
5
Induction chemotherapy plus concomitant chemoradiotherapy in nasopharyngeal carcinoma: An updated network meta-analysis.诱导化疗联合同期放化疗治疗鼻咽癌：一项更新的网络荟萃分析。
Crit Rev Oncol Hematol. 2021 Apr;160:103244. doi: 10.1016/j.critrevonc.2021.103244. Epub 2021 Feb 11.
6
Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.鼻咽癌：ESMO-EURACAN诊断、治疗及随访临床实践指南
Ann Oncol. 2021 Apr;32(4):452-465. doi: 10.1016/j.annonc.2020.12.007. Epub 2020 Dec 25.
7
Recurrent Nasopharyngeal Cancer: Critical Review of Local Treatment Options Including Recommendations during the COVID-19 Pandemic.复发性鼻咽癌：包括COVID-19大流行期间建议在内的局部治疗选择的批判性综述
Cancers (Basel). 2020 Nov 25;12(12):3510. doi: 10.3390/cancers12123510.
8
Meta-Analysis on Induction Chemotherapy in Locally Advanced Nasopharyngeal Carcinoma.局部晚期鼻咽癌诱导化疗的荟萃分析。
Oncologist. 2021 Jan;26(1):e130-e141. doi: 10.1002/ONCO.13520. Epub 2020 Oct 1.
9
Adding Concurrent Chemotherapy to Intensity-Modulated Radiotherapy Does Not Improve Treatment Outcomes for Stage II Nasopharyngeal Carcinoma: A Phase 2 Multicenter Clinical Trial.同步化疗联合调强放疗对II期鼻咽癌治疗效果无改善：一项II期多中心临床试验
Front Oncol. 2020 Aug 7;10:1314. doi: 10.3389/fonc.2020.01314. eCollection 2020.
10
Population-based risk assessment of second primary cancers following a first head and neck cancer: patterns of association and difficulties of its analysis.基于人群的首次头颈部癌症后第二原发癌风险评估：关联模式及其分析难点。
Clin Transl Oncol. 2021 Apr;23(4):788-798. doi: 10.1007/s12094-020-02470-z. Epub 2020 Aug 19.